Ecosystem

Artgen is developing an internal ecosystem to accelerate the group’s biotech companies and commercialize their developments.

The implementation of developments includes a number of steps that require different professional knowledge and expertise. Generally, for effective development, biotech startups need to cooperate with specialized companies that have the necessary expertise and competencies. These include contract research organizations, patent companies, contract manufacturing organizations, investment bankers, etc.

The biotech industry and biotech companies grow successfully if the economy conditions are favorable and there is an appropriate industry infrastructure and ecosystem.

In Russia, several development institutions have been created over the past few years, and such an ecosystem has been built in part, however, many infrastructure elements are still lacking for the successful development of the biotechnology sector.

Artgen is creating an internal biotech ecosystem which will translate its unique expertise in science, regulation, research, medicine, production, patenting, marketing, investment to the group’s companies.

Artgen’s biotech ecosystem increases the probability of success and the speed of implementation of developments, while being an independent source of value generation and capital growth.